Single-domain antibodies for biomedical applications

被引:55
|
作者
Krah, Simon [1 ]
Schroeter, Christian [1 ]
Zielonka, Stefan [2 ]
Empting, Martin [3 ]
Valldorf, Bernhard [2 ]
Kolmar, Harald [2 ]
机构
[1] Merck KGaA, Merck Serono, Prot Engn & Antibody Technol, Darmstadt, Germany
[2] Tech Univ Darmstadt, Inst Organ Chem & Biochem, Alarich Weiss Str 4, D-64287 Darmstadt, Germany
[3] Univ Saarland, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Drug Design & Optimizat, D-66123 Saarbrucken, Germany
关键词
VHH; heavy chain antibody; Antibody engineering; antibody fragment; single chain binding domain; IgNAR; SHARK IGNAR ANTIBODY; ANTIGEN RECEPTOR IGNAR; VARIABLE DOMAINS; BIOPHYSICAL PROPERTIES; AFFINITY MATURATION; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; SELECTION; FRAGMENTS; NANOBODY;
D O I
10.3109/08923973.2015.1102934
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Single-domain antibodies are the smallest antigen-binding units of antibodies, consisting either only of one variable domain or one engineered constant domain that solely facilitates target binding. This class of antibody derivatives comprises naturally occurring variable domains derived from camelids and sharks as well as engineered human variable or constant antibody domains of the heavy or light chain. Because of their high affinity and specificity as well as stability, small size and benefit of multiple re-formatting opportunities, those molecules emerged as promising candidates for biomedical applications and some of these entities have already proven to be successful in clinical development.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 50 条
  • [31] A synthetic library for rapid isolation of humanized single-domain antibodies
    Ju, Man-Seok
    Min, Sung-Won
    Lee, Sang Min
    Kwon, Hyeong Sun
    Park, Jong Chan
    Lee, Ji Chul
    Jung, Sang Taek
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2017, 22 (03) : 239 - 247
  • [32] Camelid Single-Domain Antibodies for the Development of Potent Diagnosis Platforms
    Brilhante-da-Silva, Nairo
    de Oliveira Sousa, Rosa Maria
    Arruda, Andrelisse
    dos Santos, Eliza Lima
    Marinho, Anna Carolina Machado
    Stabeli, Rodrigo Guerino
    Fernandes, Carla Freire Celedonio
    Pereira, Soraya dos Santos
    MOLECULAR DIAGNOSIS & THERAPY, 2021, 25 (04) : 439 - 456
  • [33] Single-Domain Antibodies as Therapeutics for Respiratory RNA Virus Infections
    Huang, Keke
    Ying, Tianlei
    Wu, Yanling
    VIRUSES-BASEL, 2022, 14 (06):
  • [34] Brain Delivery of Single-Domain Antibodies: A Focus on VHH and VNAR
    Pothin, Elodie
    Lesuisse, Dominique
    Lafaye, Pierre
    PHARMACEUTICS, 2020, 12 (10) : 1 - 16
  • [35] A synthetic library for rapid isolation of humanized single-domain antibodies
    Man-Seok Ju
    Sung-Won Min
    Sang Min Lee
    Hyeong Sun Kwon
    Jong Chan Park
    Ji Chul Lee
    Sang Taek Jung
    Biotechnology and Bioprocess Engineering, 2017, 22 : 239 - 247
  • [36] Orally delivered single-domain antibodies against gastrointestinal pathogens
    Petersson, Marcus
    Thrane, Sandra W.
    Gram, Lone
    Muyldermans, Serge
    Laustsen, Andreas H.
    TRENDS IN BIOTECHNOLOGY, 2023, 41 (07) : 875 - 886
  • [37] Single-Domain Antibodies As Therapeutics against Human viral Diseases
    Wu, Yanling
    Jiang, Shibo
    Ying, Tianlei
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [38] Camelid Single-Domain Antibodies for the Development of Potent Diagnosis Platforms
    Nairo Brilhante-da-Silva
    Rosa Maria de Oliveira Sousa
    Andrelisse Arruda
    Eliza Lima dos Santos
    Anna Carolina Machado Marinho
    Rodrigo Guerino Stabeli
    Carla Freire Celedonio Fernandes
    Soraya dos Santos Pereira
    Molecular Diagnosis & Therapy, 2021, 25 : 439 - 456
  • [39] Antigen recognition by single-domain antibodies: structural latitudes and constraints
    Henry, Kevin A.
    MacKenzie, C. Roger
    MABS, 2018, 10 (06) : 815 - 826
  • [40] Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook
    Arbabi-Ghahroudi, Mehdi
    FRONTIERS IN IMMUNOLOGY, 2017, 8